PLUR
Pluri Inc.
NASDAQ: PLUR · HEALTHCARE · BIOTECHNOLOGY
$3.42
+1.48% today
Updated 2026-04-29
Market cap
$36.85M
P/E ratio
—
P/S ratio
27.52x
EPS (TTM)
$-3.31
Dividend yield
—
52W range
$3 – $6
Volume
0.0M
WallStSmart proprietary scores
17
out of 100
Grade: F
Strong Sell
Investment rating
6.7
Growth
B5.0
Quality
C+2.5
Profitability
F5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$12.00
+250.88%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-5.65M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $234000.00 | $287000.00 | $326000.00 | $1.34M | $1.34M |
| Net income | $-41.24M | $-28.32M | $-20.89M | $-22.58M | $-6.54M |
| EPS | — | — | — | — | $-3.31 |
| Free cash flow | $-36.78M | $-23.12M | $-18.34M | $-19.83M | $-5.65M |
| Profit margin | -17,624.79% | -9,867.94% | -6,407.36% | -1,690.34% | — |
Peer comparison
Smart narrative
Pluri Inc. trades at $3.42. Our Smart Value Score of 17/100 indicates the stock is weak. TTM revenue stands at $1.34M.
Frequently asked questions
What is Pluri Inc.'s stock price?
Pluri Inc. (PLUR) trades at $3.42.
Is Pluri Inc. overvalued?
Smart Value Score 17/100 (Grade F, Strong Sell).
What is the price target of Pluri Inc. (PLUR)?
The analyst target price is $12.00, representing +250.9% upside from the current price of $3.42.
What is Pluri Inc.'s revenue?
TTM revenue is $1.34M.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio27.52x
ROE-1,022.00%
Beta0.72
50D MA$3.40
200D MA$3.92
Shares out0.01B
Float0.00B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—